![](https://etimg.etb2bimg.com/thumb/msid-111837980,imgsize-323550,width-1200,height=765,overlay-ethealth/pharma/pharma-industry/as-roche-blocks-zydus-pertuzumab-launch-experts-see-murky-corporate-rivalry.jpg)
As Roche blocks Zydus’ Pertuzumab launch, experts see murky corporate rivalry
Mumbai: Sigrima, Zydus Lifesciences’ biosimilar challenge to Roche’s breast cancer blockbuster brand Perjeta is swirling into controversies. After a recent injunction against its launch from the Delhi High Court on charges of concealing key regulatory …